Cargando…
Basic and clinical immunology – 3032. 18FDG-PET/CT findings (SUV-MAX) are correlated with survival in stage-4 squamous cell carcinoma
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Allergy Organization
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3643698/ http://dx.doi.org/10.1186/1939-4551-6-S1-P207 |
_version_ | 1782268358676185088 |
---|---|
author | Yalcin, Arzu Didem Erkilic, Metin Kargi, Bulent Kargi, Aysegul Savas, Burhan Dimitrakopoulou-Strauss, Antonia Strauss, Ludwig |
author_facet | Yalcin, Arzu Didem Erkilic, Metin Kargi, Bulent Kargi, Aysegul Savas, Burhan Dimitrakopoulou-Strauss, Antonia Strauss, Ludwig |
author_sort | Yalcin, Arzu Didem |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-3643698 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | World Allergy Organization |
record_format | MEDLINE/PubMed |
spelling | pubmed-36436982013-05-09 Basic and clinical immunology – 3032. 18FDG-PET/CT findings (SUV-MAX) are correlated with survival in stage-4 squamous cell carcinoma Yalcin, Arzu Didem Erkilic, Metin Kargi, Bulent Kargi, Aysegul Savas, Burhan Dimitrakopoulou-Strauss, Antonia Strauss, Ludwig World Allergy Organ J Meeting Abstract World Allergy Organization 2013-04-23 /pmc/articles/PMC3643698/ http://dx.doi.org/10.1186/1939-4551-6-S1-P207 Text en Copyright ©2013 Yalcin et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Meeting Abstract Yalcin, Arzu Didem Erkilic, Metin Kargi, Bulent Kargi, Aysegul Savas, Burhan Dimitrakopoulou-Strauss, Antonia Strauss, Ludwig Basic and clinical immunology – 3032. 18FDG-PET/CT findings (SUV-MAX) are correlated with survival in stage-4 squamous cell carcinoma |
title | Basic and clinical immunology – 3032. 18FDG-PET/CT findings (SUV-MAX) are correlated with survival in stage-4 squamous cell carcinoma |
title_full | Basic and clinical immunology – 3032. 18FDG-PET/CT findings (SUV-MAX) are correlated with survival in stage-4 squamous cell carcinoma |
title_fullStr | Basic and clinical immunology – 3032. 18FDG-PET/CT findings (SUV-MAX) are correlated with survival in stage-4 squamous cell carcinoma |
title_full_unstemmed | Basic and clinical immunology – 3032. 18FDG-PET/CT findings (SUV-MAX) are correlated with survival in stage-4 squamous cell carcinoma |
title_short | Basic and clinical immunology – 3032. 18FDG-PET/CT findings (SUV-MAX) are correlated with survival in stage-4 squamous cell carcinoma |
title_sort | basic and clinical immunology – 3032. 18fdg-pet/ct findings (suv-max) are correlated with survival in stage-4 squamous cell carcinoma |
topic | Meeting Abstract |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3643698/ http://dx.doi.org/10.1186/1939-4551-6-S1-P207 |
work_keys_str_mv | AT yalcinarzudidem basicandclinicalimmunology303218fdgpetctfindingssuvmaxarecorrelatedwithsurvivalinstage4squamouscellcarcinoma AT erkilicmetin basicandclinicalimmunology303218fdgpetctfindingssuvmaxarecorrelatedwithsurvivalinstage4squamouscellcarcinoma AT kargibulent basicandclinicalimmunology303218fdgpetctfindingssuvmaxarecorrelatedwithsurvivalinstage4squamouscellcarcinoma AT kargiaysegul basicandclinicalimmunology303218fdgpetctfindingssuvmaxarecorrelatedwithsurvivalinstage4squamouscellcarcinoma AT savasburhan basicandclinicalimmunology303218fdgpetctfindingssuvmaxarecorrelatedwithsurvivalinstage4squamouscellcarcinoma AT dimitrakopouloustraussantonia basicandclinicalimmunology303218fdgpetctfindingssuvmaxarecorrelatedwithsurvivalinstage4squamouscellcarcinoma AT straussludwig basicandclinicalimmunology303218fdgpetctfindingssuvmaxarecorrelatedwithsurvivalinstage4squamouscellcarcinoma |